30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: DJO Global

$294.7MM, +3%

  • Bracing/Vascular $119.4MM, +5%
  • Recovery Sciences $77.2MM, -8%
  • International $76.8MM, +8%
  • Surgical Implant $21.4MM, +18%

(Bracing and Vascular includes products serving the diabetes market.)

  • Bracing/Vascular buoyed by new products, including Aircast AirSelect walking boot
  • Recovery Sciences still impacted by 2012 Medicare non-coverage decision on Transcutaneous Electrical Nerve Stimulation for low back pain, slow market for capital equipment purchase
  • Surgical Implant driven by shoulder arthroplasty, which grew 25%+; hip and knee growing ahead of market
  • Noting significant growth headwinds in joint reconstruction sector
  • In 3Q, launched Empi Phoenix muscle stimulator for total knee and ACL recovery, addresses muscle atrophy